Samjin Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Samjin Pharmaceutical Company Limited with three other
companies in this sector in South Korea:
Dong Wha Pharm Company Limited
sales of 237.47 billion Korean Won [US$212.77 million]
of which 100%
KolmarBNH Co Ltd
(256.01 billion Korean Won [US$229.38 million]
of which 90%
was Biotech), and
Daewon Pharmaceutical Co Ltd
(240.72 billion Korean Won [US$215.69 million]
of which 99%
Samjin Pharmaceutical Company Limited reported sales of 239.31 billion Korean Won (US$214.42 million)
December of 2016.
increase of 10.5%
versus 2015, when the company's sales were 216.51 billion Korean Won.
This was the fourth straight year of sales growth at Samjin Pharmaceutical Company Limited.